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Abstract
Persons with schizophrenia spectrum disorders (SSDs) are not only at risk because of disabling
disease symptoms but because necessary medications create health risks associated with high rates
of obesity. Despite the well-known benefits of exercise, persons with SSDs rarely adhere to such
regimens; few interventions to motivate exercise behavior have been tested in this group.
The purpose of this study is to examine effects of the Walk, Address sensations, Learn about exercise,
Cue exercise behavior for persons with SSDs (WALC-S) motivational intervention upon exercise
behavior. We will recruit a total of eighty outpatients 18–68 years, meeting these criteria: 1) chart
diagnosis of schizophrenia, any subtype, schizoaffective disorder or schizophreniform disorder,
according to the criteria described in the Diagnostic and Statistical Manual for Mental Disorders, 2)
English speaking, 3) Stable medication regimen (defined as no medication changes within the last
month), and 4) medical clearance for moderate exercise in writing from primary care provider.
Participants will be randomly assigned to the experimental (4-week WALC-S motivational
intervention), or the control group (4-week time and attention control). After the first 4 weeks, all
participants will attend a 16-week walking group.
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The primary measures of the effectiveness of the WALC-S are attendance, persistence and
compliance to the 16-week walking group. The study will be completed in approximately January
2010. In addition to hypothesis testing, this study will provide information to estimate effect sizes
to calculate power and determine appropriate sample sizes for future inquiries. This paper describes
the rationale and design of the study.
Keywords
Schizophrenia; exercise; motivation; psychosocial interventions
Introduction
Schizophrenia spectrum disorders (SSDs) include schizophrenia, schizoaffective disorder and
schizophreniform disorder. The diagnostic overlap between the three is well known (1); recent
research indicates that persons with these disorders have similar psychiatric symptoms (2) and
cognitive deficits (3,4). Another commonality is the increased risk for adverse physical health
outcomes shared by persons with these illnesses.
Death rates from diabetes, respiratory/cardiovascular, and other obesity-related illnesses are
significantly higher among the over 2 million Americans with SSDs than in the general
population (5). The most effective medications for managing SSDs (second generation
antipsychotics such as clozapine and olanzapine) are associated with weight gain, glucose
dysregulation and diabetes (6,7,8). Despite the well-known benefits of exercise and the health
dangers associated with obesity, persons with SSDs rarely adhere to exercise regimens and
few exercise adherence interventions have been tested in this group.
Few published studies have examined the effects of exercise in persons with SSDs (9,10,11,
12,13,14,15) and only two addressed exercise motivation (16,17). All of the studies examining
psychiatric outcomes reported symptom improvement (9,10,11,12); three of four studies
addressing physical health outcomes reported positive changes (12,13,14,15). Drop out rates
ranged from 5 to 38% over periods from 8–16 weeks in length. Attendance at exercise sessions
ranged from 23% to 91% with attendance being positively correlated with degree of
improvement. Archie et al., (16) provided free access to a fitness facility to 20 outpatients with
schizophrenia for 6 months and monitored their exercise behavior. Dropout rates were 40%
after 4 months, 70% after 5 months and 90% after 6 months. These rates compare unfavorably
with exercise cessation in the general population, which is approximately 50% after 6 months
(24). The most common reason given for poor attendance at the exercise facility was lack of
motivation (16). Menza and colleagues (17) tested a one-year weight control program in 31
outpatients with SSDs. The program incorporated exercise as well as behavioral interventions,
and compared BMI and weight with a control group of 20 non-intervention patients. Weight
and BMI decreased significantly in the intervention group, with 20 of 31 persons completing
the study, for a one-year retention rate of 66% (69% of sessions were attended). The study
intervention consisted of nutritional counseling, exercise, and behavioral interventions
incorporating motivational counseling techniques. Motivational counseling consisted of
professional support, encouragement, and strategies to improve exercise habits. This study
shows that interventions can increase exercise adherence in persons with SSDs. However,
because the control group had no opportunity to participate in an exercise program, it is not
possible to separate the motivational effects of the intervention from the motivational effects
of exercise alone. Our study addresses this limitation by offering an exercise group to every
participant.
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This paper reviews the rationale and design of our study. The purpose of this study is to test
the effects of the Walk, Address sensations, Learn about exercise, Cue exercise behavior for
persons with SSDs (WALC-S) motivational intervention on the following three aspects of
exercise behavior:
• Attendance-The ratio of the total number of exercise sessions attended to the total
number of exercise sessions offered;
• Persistence-The number of consecutive weeks that the participant attends at least one
exercise session; and
• Compliance-The performance of activities during exercise sessions.
We hypothesize that experimental participants will have higher: 1) attendance rates, 2)
persistence rates and 3) compliance rates at the exercise program than controls.
Design
This experimental study is testing the WALC-S motivational intervention by comparing the
attendance, persistence and compliance of an experimental group of persons with SSDs (who
receive the WALC-S intervention) with the exercise attendance, persistence and compliance
of a time-and-attention control group (not receiving the WALC-S intervention). The WALC-
S and the time and attention control will be provided prior to a 16-week walking group that
will be offered to all participants. (See Figure 1).
Motivational intervention—The Walk, Address sensations, Learn about exercise, Cue
exercise behavior (WALC) was originally designed to motivate community-dwelling older
adults to exercise. The WALC is based upon self-efficacy theory and has been theoretically
and empirically validated (18–23). Persons with SSDs face many similar exercise barriers as
elderly persons. Research has shown that both elderly persons and those with SSDs lack
exercise motivation (16,23,24). Further, elderly persons perceive the following barriers to
exercise: fear of pain (18), problems with goal setting (25), and lack of knowledge regarding
the positive benefits of exercise (15,24–26). Problems with goal setting may be partially related
to cognitive deficits associated with aging (27,28). The literature supports the presence of
similar exercise barriers among persons with SSDs. Persons with SSDs have documented
cognitive deficits that lead to difficulties setting goals and carrying out goal directed plans
(29). In one study, over 33% of persons cited fear of pain as a barrier to exercise participation
and participants reported that health benefits experienced were unexpected (12), highlighting
the similarities with elderly persons who lack knowledge as to the strong relationship of health
benefits and exercise (25). We believe these similarities make the use of the WALC a
reasonable starting point in our search for interventions to increase exercise behavior in persons
with SSDs.
Enrollment criteria
The sample will be selected from persons with SSDs aged 18–68 years, receiving outpatient
care at a community agency and meeting the following criteria: 1) a chart diagnosis of
schizophrenia (any subtype), schizoaffective disorder or schizophreniform disorder, according
to the criteria described in the Diagnostic and Statistical Manual-IV for Mental Disorders (1),
2) English speaking, 3) Stable medication regimen (defined as no medication changes within
the last month), and 4) medical clearance for moderate exercise in writing from primary care
provider.
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Exclusion criteria include chart documentation of mental retardation, developmental delay,
uncorrected visual, hearing impairments or any physiological condition preventing safe
participation. Persons with the following physical conditions per chart documentation are
excluded: 1) hospitalization within the past 12 months for angina pectoris, myocardial
infarction, or cardiac surgery of any kind, 2) congestive heart failure, 3) cardiac pacemaker,
4) heart rate > 100 or < 50 at rest, 5) uncontrolled hypertension defined as a blood pressure
exceeding 140/90 on 3 consecutive readings despite adequate treatment, 6) history of spinal
or hip fractures or hip or knee arthroplasty, 7) neuromuscular or orthopedic limitations to
normal, unassisted ambulation, and 8) other medical conditions that, in the opinion of the
primary care provider or investigators, involve risk exceeding the potential benefit of
participation.
Our enrollment target is 80 participants. Allowing for a 20% attrition rate, it is estimated that
approximately 64 participants (32 per group) will complete the study. (See Figure 2). We use
a computer-generated random number table to assign patients to either the control or the
intervention group in a 1:1 ratio. The randomization process is expected to result in equal
distribution of important sociodemographic and illness variables between the two groups. The
sample will not be stratified by gender, ethnicity, or other variables, since no data are available
at this time to indicate differential response to the intervention based upon differences between
participants.
Study Interventions
Upon study entry, participants are randomly assigned to either the experimental or control
group. Experimental participants (8–9 persons per group) attend the one-hour WALC-S
motivational group weekly for 4 weeks prior to their 16-week walking group. The WALC-S
was designed to address cognitive deficits common to persons with SSDs. While variability
exists between individuals, cognitive impairments are present to some degree in virtually every
SSD (30). Specific deficits include mild-to-moderate impairment in attention and memory and
severe impairment in executive functioning (31–32). Executive functioning deficits involve
frontal lobe dysfunction in the areas of planning, organization, and mental flexibility (30) that
impede problem solving and decision making processes (33). We used a number of strategies
to offset these difficulties. For example, we addressed memory deficits (34) through repetition
of information during WALC-S sessions, and by providing written and verbal reminders of
WALC-S groups. To assist participants to sustain attention during WALC-S groups,
information was presented in a variety of formats: first verbally, then pictorially with visual
aids, and finally demonstrated in person. Research staff assisted with goal setting and
identifying ways to overcome exercise barriers in order to offset difficulties with problem
solving and decision making (35). Finally, because participants in prior studies cited the
importance of the social aspects of exercise (36), we designed the WALC-S as a one-hour
group intervention (8–9 participants per group) that met weekly for four weeks.
The WALC-S intervention is not a walking group; rather, it is a forum for discussion of the
basics of walking for exercise supplemented by a booklet provided to every experimental
participant. The group practices a series of basic stretches at each meeting. Study personnel
assist with goal setting, a process that is difficult for persons with schizophrenia due to
limitations in executive functioning (35,37). Study personnel provide suggestions on reducing
common exercise discomforts, such as using heat or massage for muscular soreness. Study
personnel provide instruction on potential exercise benefits and overcoming barriers to
exercise. Participants are provided with reminder calendars to track WALC-S attendance and
any other exercises performed independently. Activities for each weekly group are listed in
Table 1.
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Control participants (8–9 persons per group) attend the one-hour time-and-attention control
group weekly for 4 weeks prior to their 16-week walking group. Control groups are conducted
by the same research staff as the WALC-S groups, and meet on the same day in the same
location for an identical period of time. Control groups focus on healthy behaviors such as
medication adherence, smoking cessation and progressive muscle relaxation.
Sixteen-week walking group (all participants). After the 4-week experimental or control group
is completed, all participants participate in a 16-week walking group. Walking groups are
conducted by different research personnel than those who led the WALC-S group or the time-
and-attention control group to minimize the effects of relationship with group leader alone
upon outcomes. Each walking group begins with a series of warm up stretches (38). Warm up
is followed by walking, beginning with 5 minutes and gradually increasing to 30 minutes over
the first four weeks. Interaction during the walking groups is social rather than therapeutic (e.g.
discussion of daily activities, family members, recreational plans, and the like). Walking group
research personnel do not initiate any discussions of WALC-S content during walking groups.
Should any participant initiate discussion or questions regarding WALC-S concepts, group
leaders respond with appropriate education, goal setting or reinforcement. For example, if a
participant remarks that he or she is experiencing less depression since beginning the walking
group, the group leader reinforces information regarding the benefits of exercise on mood, but
refrains from initiating any such discussions. Research personnel note that this has occurred
on only one occasion; thus, we estimate that the likelihood of the blind being broken as a result
of discussion of WALC-S training during the walking groups, appears to be minimal. Each
walking session concludes with a series of cool down stretches. Walking sessions occur
outdoors (weather permitting) at the recruitment facility on Monday, Wednesday, and Friday,
either in the morning or afternoon. Control and experimental participants do not attend the
same walking group, in order to prevent cross-contamination.
Treatment Fidelity
Two different research personnel blinded to treatment group are providing walking groups to
experimental and control participants. The first author conducted an 8-hour training session
before any walking groups; both personnel scored 100% on a knowledge test after the training.
The first author provides at least 2 hours of supervision each week, and attends 50% of the
walking groups. A measure of concurrence with the walking group training is generated by
completion of a fidelity form once a month. The form provides an objective measure of the
provision of each aspect of the walking group, ranging from 1-none of the time to 5-all of the
time. The first author provides remediation for any area that scores below 4-most of the time.
Remediation is organized accordingly: (1) identification of specific concerns or questions, (2)
item-by-item discussion of walking group procedures, (3) provision of feedback and
clarification, and (4) immediate correction of deficiencies. These activities ensure that the
walking groups are implemented as stated, increasing uniformity and reducing alternative
explanations based upon differences in walking group procedures.
Outcomes
Walking group attendance will be measured as a ratio of number of exercise sessions attended
to total number of exercise sessions offered. For example, a person attending 24 exercise group
sessions of the total 48 sessions offered would have an attendance rate of 50%. Walking group
persistence will be measured as the number of consecutive weeks that the participant attends
at least one walking group. Walking group compliance is measured by pedometer. The number
of steps walked per group will be used to generate an ordinal measure of compliance as follows:
Full-The number of steps equals or exceeds that of the previous walking group; Partial-The
number of steps is not more than 10% less than that of the previous walking group; None-The
number of steps is more than 10% less than that of the pervious walking group.
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Data Collection will occur over a two-year period. Data regarding sociodemographic
characteristics, living arrangements, prescribed medications and medication and/or dosage
changes will be collected on all participants at study entry. Attendance, persistence, and
compliance are documented at each walking group. Sixty-four participants have been recruited;
this partial sample consists mostly of female (n = 36, 56.3%) Caucasians (n = 42, 65.6%) from
24–68 years with a mean age of 47.88 (SD 8.85). The majority live with family members (n =
30, 46.9%). Forty-eight participants have completed all study activities including descriptive
measures, the WALC-S or the time-and-attention control group, and the 16-week walking
group with its associated measures of attendance, persistence and compliance.
Data Analysis Plan
The Statistical Package for the Social Sciences (SPSS) and the Statistical Analysis System
(SAS) will be used to analyze the data. Data analysis will begin with data plots and basic
descriptive statistics appropriate for the level of measurement. Groups will be compared for
pretreatment equivalence on sociodemographic characteristics, as well as type and dosage of
prescribed medications. Expected mean squares will be calculated and the appropriate
combination will be used for hypothesis tests with specific functions of the repeated measures.
General linear model analyses in SAS (GLM and MIXED procedures) will be used to examine
the effects of time, treatment, and time by treatment interaction. For hypotheses 1 and 2, a
sample size of 32 in each group will have 80% power to detect an effect size of 0.629 using a
two-group t-test with a 0.05 one-sided significance level. For hypothesis 3, a sample size of
32 in each group will have 80% power to detect a probability of 0.679 that an observation in
the control group is less than an observation in the experimental group using a Wilcoxon rank-
sum test with a 0.05 one-sided significance level.
Summary
In addition to hypothesis testing, this study will provide information to estimate effect sizes to
calculate power and determine appropriate sample sizes for future inquiries. This work is the
first step toward our ultimate goal of developing and empirically evaluating exercise
interventions to enhance health for persons with SSDs.
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Table 1
Activities and materials for the WALC-S.
Week Activities and Materials
One
Introductions of research staff and group members
Review section of booklet on basics of exercising safely
Perform stretches: Poster with photograph of each stretch, demonstration by research staff and return
demonstration by group members
Two
Introductions and Check-in with each member
Review section of booklet on basics of exercising safely
Review section of booklet on exercise benefits
Perform stretches: Poster with photograph of each stretch, demonstration by research staff and return
demonstration by group members
Three
Introductions and Check-in with each member
Review section of booklet on basics of exercising safely
Review section of booklet on exercise benefits
Barriers and solutions: Discuss and write suggestions for dealing with common exercise barriers on
blackboard.
Perform stretches: Poster with photograph of each stretch, demonstration by research staff and return
demonstration by group members
Four
Introductions and Check-in with each member
Review section of booklet on basics of exercising safely
Review section of booklet on exercise benefits
Barriers and solutions: Discuss and write suggestions for dealing with common exercise barriers on
blackboard.
Set individual goals
Provide reminder calendars to cue exercise
Perform stretches: Poster with photograph of each stretch, demonstration by research staff and return
demonstration by group members
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